公开(公告)号：US20160038093A1

公开(公告)日：2016-02-11

申请号：US14798225

申请日：2015-07-13

Applicant: Medtronic, Inc.

Inventor： Vinod Sharma ,  Eduardo N. Warman ,  Karen J. Kleckner

IPC: A61B5/00

CPC classification number: A61B5/7275 ,  A61B5/0031 ,  A61B5/0205 ,  A61B5/0432 ,  A61B5/044 ,  A61B5/046 ,  A61B5/0464 ,  A61B5/0537 ,  A61B5/1118 ,  A61B5/14503 ,  A61B5/14532 ,  A61B5/14535 ,  A61B5/14546 ,  A61B5/4836 ,  A61B5/686 ,  A61B5/6869 ,  A61B5/7278 ,  A61B5/7435 ,  A61B5/7475 ,  A61B2505/07 ,  G06F19/00 ,  G16H15/00 ,  G16H50/20 ,  G16H50/30

Abstract: A method of operation of a medical device system for determining prospective heart failure hospitalization risk. The method includes measuring one or more data observations via one or more electrodes of an implanted medical device disposed in a patient's body. The data observations are stored into memory of the implantable medical device of a patient. The data observations are transmitted to an external device. The processor of the external device parses the data observations into one or more evaluation periods. Using the number of observations in one or more evaluation periods, a look up table, stored into memory of the external device, is accessed. The look up table associates prospective heart failure hospitalization risk with the data observations noted in the evaluation period. One or more embodiments involve a weighted prospective heart failure hospitalization risk for the set of evaluation periods. The prospective heart failure hospitalization is then displayed on the graphical user interface.

Abstract translation: 一种用于确定预期心脏衰竭住院风险的医疗装置系统的操作方法。 该方法包括通过设置在患者体内的植入医疗装置的一个或多个电极来测量一个或多个数据观察。 数据观察被存储到患者的可植入医疗装置的存储器中。 数据观测被发送到外部设备。 外部设备的处理器将数据观察结果解析为一个或多个评估周期。 使用在一个或多个评估周期中的观察次数，访问存储在外部设备的存储器中的查找表。 查看表将前瞻性心力衰竭住院风险与评估期间注意到的数据观察结果相关联。 一个或多个实施例涉及该组评估周期的加权前瞻性心力衰竭住院风险。 然后将预期的心力衰竭住院治疗显示在图形用户界面上。

公开(公告)号：US20150141851A1

公开(公告)日：2015-05-21

申请号：US14172378

申请日：2014-02-04

Applicant: Medtronic, Inc.

Inventor： Vinod Sharma

IPC: A61B5/0205 ,  A61B5/04 ,  A61B5/0432 ,  A61B5/0464 ,  A61B5/0408 ,  A61B5/11 ,  A61B5/00

Abstract: An implantable monitoring device is disclosed for monitoring a patient's heart rate variability over time. The device includes a cardiac electrogram amplifier, a sensing electrode coupled to an input of the amplifier, timing circuitry, processing circuitry and a memory. The timing circuitry defines successive shorter time periods during each monitoring period. The processing circuitry relies upon electrogram activity that occurs during rest periods that extend as long as T1, all of which is stored into memory. Active periods are not considered as part of the heart rate variability calculation. The processing circuitry calculates median intervals between depolarizations of the patient's heart sensed by the amplifier during the shorter time periods and calculates a standard deviation of the median intervals during T2, a longer monitoring period.

Abstract translation: 公开了一种用于随时间监测患者的心率变异性的可植入监测装置。 该装置包括心电图放大器，耦合到放大器的输入的感测电极，定时电路，处理电路和存储器。 定时电路在每个监测周期期间定义连续较短的时间段。 处理电路依赖于在静止期间发生的电描记图活动，其延伸长达T1，所有这些都存储在存储器中。 活动期不被视为心率变异性计算的一部分。 处理电路计算在较短时间段期间由放大器感测到的患者心脏的去极化之间的中间间隔，并计算T2期间的中位数间隔的标准偏差，监测期较长。

公开(公告)号：US12226226B2

公开(公告)日：2025-02-18

申请号：US16922326

申请日：2020-07-07

Applicant: Medtronic, Inc.

Inventor： Vinod Sharma ,  Eduardo N. Warman ,  Shantanu Sarkar ,  Tommy D. Bennett ,  Lindsay M. Streeter ,  Jennifer K. Bravinder

IPC: A61B5/00 ,  A61B5/0205 ,  A61B5/07 ,  G16H20/10 ,  G16H40/40 ,  G16H40/63 ,  G16H50/30 ,  A61B5/021 ,  A61B5/0215 ,  A61B5/053 ,  A61J1/00 ,  A61N1/362 ,  A61N1/365 ,  A61N1/39 ,  G01G19/44 ,  G16H20/13 ,  G16H40/67

Abstract: Methods and systems for seamless adjustment of treatment are disclosed. A determination is made as to whether to intervene with a patient's treatment. Implanted device memory data is acquired over a pre-specified time period. Risk status is determined from the device memory data. Another external device memory data is acquired over a pre-specified time period. A determination is made as to whether to adjust treatment of the patient in response to the risk status, the data acquired from the implanted device memory and the external device memory data.

公开(公告)号：US20240307689A1

公开(公告)日：2024-09-19

申请号：US18263669

申请日：2022-02-24

Applicant: Medtronic, Inc.

Inventor： Vinod Sharma ,  Andrew J. Cleland ,  Nathan A. Torgerson ,  Benjamin P. Isaacson ,  Jeffery M. Kramer ,  Juan G. Hincapie ,  Brooke G. Kelley ,  Leonid M. Litvak ,  Paula Andrea Elma Dassbach Green ,  Michelle A. Case

IPC: A61N1/36

CPC classification number: A61N1/36132 ,  A61N1/36139

Abstract: An example system includes electrical stimulation circuitry configured to generate electrical stimulation, electrodes configured to deliver the electrical stimulation to a patient, and processing circuitry configured to determine, for a patient, a first cycling of electric stimulation doses. The processing circuitry is also configured to deliver the electric stimulation doses according the determined first cycling, receive patient feedback representing a response of the patient to the electric stimulation doses delivered according to the first cycling, determine, based on the patient feedback, a second cycling of the electric stimulation doses, and deliver the electric stimulation doses to the patient according the determined second cycling. Delivering the electric stimulation doses for the patient according to the determined second cycling consumes less power of the implanted device than delivering the electric stimulation doses for the patient according to the determined first cycling.

公开(公告)号：US11744478B2

公开(公告)日：2023-09-05

申请号：US16511932

申请日：2019-07-15

Applicant: Medtronic, Inc.

Inventor： Vinod Sharma ,  Jodi L. Redemske

IPC: A61N1/365 ,  A61B5/0537 ,  A61B5/0538 ,  A61B5/00 ,  A61N1/372 ,  A61N1/37

CPC classification number: A61B5/0537 ,  A61B5/0538 ,  A61B5/7275 ,  A61N1/36521 ,  A61N1/3702 ,  A61N1/37258

Abstract: A health care system acquires data determines whether a patient is at risk of hypervolemia or hypovolemia. The method comprises (a) acquiring from a device memory a patient's absolute intrathoracic impedance data over a pre-specified time period, (b) determining a running average of the intrathoracic impedance data over the pre-specified time period, and (c) determining by the system whether the running average of the intrathoracic impedance data over the pre-specified time period exceeds one of a first and second range, the first range being a higher value boundary of intrathoracic electrical impedance and the second range being a lower value boundary of intrathoracic electrical impedance.

公开(公告)号：US20200376279A1

公开(公告)日：2020-12-03

申请号：US16878740

申请日：2020-05-20

Applicant: Medtronic, Inc.

Inventor： Vinod Sharma

IPC: A61N1/365

Abstract: Some aspects relate to systems, devices, and methods of delivering rate responsive pacing therapy. The method includes monitoring activity information related to an activity level of a patient and delivering rate responsive pacing (RRP) to the patient at a pacing rate corresponding to a RRP profile. The RRP profile may be used to generate the pacing rate based on the activity information and may be adjusted based on the monitored activity information.

公开(公告)号：US20190329043A1

公开(公告)日：2019-10-31

申请号：US16394942

申请日：2019-04-25

Applicant: Medtronic, Inc.

Inventor： Vinod Sharma

IPC: A61N1/365 ,  A61N1/372 ,  A61B5/00

Abstract: Methods and systems for seamless adjustment of treatment are disclosed. A determination can be made as to whether to intervene with a patient's treatment based on data obtained from implantable electrodes and/or non-implantable electrodes. The data from non-implantable electrodes have a correction factor applied to adjust for less accuracy compared to data acquired from implantable electrodes.

公开(公告)号：US20190125273A1

公开(公告)日：2019-05-02

申请号：US15963448

申请日：2018-04-26

Applicant: Medtronic, Inc.

Inventor： Vinod Sharma ,  Joel R. Lauer ,  Holly S. Norman

IPC: A61B5/00 ,  A61B5/053 ,  A61B5/0402

Abstract: A method and device for differentiating heart failure risk scores that includes determining receipt of a current data transmission and acquiring patient metrics from a remote monitoring device, determining a daily heart failure risk score for each day occurring during a time period from a previous received data transmission to the current received data transmission based on the acquired patient metrics, and determining a maximum daily heart failure risk score of the determined daily heart failure risk scores during a lookback window prior to the current received data transmission. A heart failure risk score is determined for the received data transmission based on the determined maximum daily heart failure risk score, and a heart failure risk score alert is determined for the received data transmission based on the proximity of the determined maximum heart failure risk score and the current received data transmission. A display of at least one of the determined heart failure risk score and the determined heart failure risk score alert is generated, and the determined daily heart failure risk score for each day occurring during the time period and the generated display are stored.

公开(公告)号：US10226197B2

公开(公告)日：2019-03-12

申请号：US14687053

申请日：2015-04-15

Applicant: Medtronic, Inc.

Inventor： James D. Reinke ,  Xusheng Zhang ,  Vinod Sharma ,  Vladimir P. Nikolski ,  Michael B. Terry ,  Scott A. Hareland ,  Daniel L. Hansen ,  Donna M. Salmi

IPC: A61B5/04 ,  A61B5/0464 ,  A61B5/00 ,  A61N1/37 ,  A61N1/39

Abstract: In situations in which an implantable medical device (e.g., a subcutaneous ICD) is co-implanted with a leadless pacing device (LPD), it may be important that the subcutaneous ICD knows when the LPD is delivering pacing, such as anti-tachycardia pacing (ATP). Techniques are described herein for detecting, with the ICD and based on the sensed electrical signal, pacing pulses and adjusting operation to account for the detected pulses, e.g., blanking the sensed electrical signal or modifying a tachyarrhythmia detection algorithm. In one example, the ICD includes a first pace pulse detector configured to obtain a sensed electrical signal and analyze the sensed electrical signal to detect a first type of pulses having a first set of characteristics and a second pace pulse detector configured to obtain the sensed electrical signal and analyze the sensed electrical signal to detect a second type of pulses having a second set of characteristics.

公开(公告)号：US10172568B2

公开(公告)日：2019-01-08

申请号：US14798225

申请日：2015-07-13

Applicant: Medtronic, Inc.

Inventor： Vinod Sharma ,  Eduardo N Warman ,  Karen J Kleckner

IPC: A61B5/00 ,  G16H50/30 ,  G16H15/00 ,  G16H50/20 ,  A61B5/0205 ,  A61B5/0432 ,  A61B5/044 ,  G06F19/00 ,  A61B5/145 ,  A61B5/11 ,  A61B5/046 ,  A61B5/053 ,  A61B5/0464

Abstract: A method of operation of a medical device system for determining prospective heart failure hospitalization risk. The method includes measuring one or more data observations via one or more electrodes of an implanted medical device disposed in a patient's body. The data observations are stored into memory of the implantable medical device of a patient. The data observations are transmitted to an external device. The processor of the external device parses the data observations into one or more evaluation periods. Using the number of observations in one or more evaluation periods, a look up table, stored into memory of the external device, is accessed. The look up table associates prospective heart failure hospitalization risk with the data observations noted in the evaluation period. One or more embodiments involve a weighted prospective heart failure hospitalization risk for the set of evaluation periods. The prospective heart failure hospitalization is then displayed on the graphical user interface.